Autres

Unlocking differentiated biology with generative AI Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets. generative AI, synthetic biology, biologics, drug … [voir plus]

Scale drug discovery with quantum-inspired physics and generative AI AQEMIA is a drug invention company dedicated to novel medicines — never me-toos — tackling major diseases such as oncology. Our physics-based, generative AI platform invents drug candidates beyond the reach of traditional R&D, without dependence on experimental data. We are … [voir plus]

Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research … [voir plus]

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to … [voir plus]

Evozyne designs novel protein therapeutics to solve previously unaddressable patient needs. [voir plus]

Pioneering generative biology to create breakthrough therapeutics. Pioneering generative biology to create breakthrough therapeutics. [voir plus]

Artificial intelligence for new drug design We are a leader in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos' proprietary and innovative generative AI solution enables the design of molecules that are optimized in silico to meet all the success criteria of … [voir plus]

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other … [voir plus]

Building the future of AI drug development with the data that matters. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and … [voir plus]

Instant research. We build data models that simulate how people think. (And no, we are not a ChatGPT wrapper.) Instant research. We build data models that simulate how your target groups think, feel, and behave. Run interviews, surveys and focus groups. On a mission to replace 20 % surveys with … [voir plus]

Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicines with Generative AI. Menten AI is pioneering generative AI to design cyclic peptide therapeutics for drug targets beyond the reach of small molecules and biologics. Our proprietary platform, MAUD 1.0, enables the rapid creation of macrocycles with drug-like properties … [voir plus]

We create the first closed-loop AI generative biology company to create the new standard of biology reasoning Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow … [voir plus]

Bridging Vision & Precision Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a … [voir plus]

The Virtual Staining Company Pictor Labs is The Virtual Staining Company enabling digital pathology adoption worldwide through AI-powered technology that delivers quality results in minutes while preserving tissue for comprehensive analysis. Our breakthrough DeepStainTM and ReStainTM solutions enable unlimited virtual staining from a single tissue sample, eliminating the bottlenecks of … [voir plus]

Grounded in nature, authored by AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX … [voir plus]

Decoding biology to radically improve lives. Powered by Recursion. Valence Labs is Recursion’s AI research engine. Leveraging the full power of Recursion’s platform, data, and computing infrastructure, we develop new ways to predict, explain, and ultimately decode biology. [voir plus]